Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation
ClinicalTrials.gov study NCT01204307. IPD Sharing: Not stated. Countries: 1. Publications: 1.
AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies
ClinicalTrials.gov study NCT02504346. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer
ClinicalTrials.gov study NCT03346811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations
ClinicalTrials.gov study NCT01024413. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT01683175. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).
ClinicalTrials.gov study NCT03562819. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation.
ClinicalTrials.gov study NCT01217619. IPD Sharing: Not stated. Countries: 1. Publications: 2.
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT03127449. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
ClinicalTrials.gov study NCT00874419. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
ClinicalTrials.gov study NCT02448797. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
ClinicalTrials.gov study NCT03992885. IPD Sharing: Not stated. Countries: 1. Publications: 2.
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04978753. IPD Sharing: NO. Countries: 1. Publications: 1.
Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
ClinicalTrials.gov study NCT05277701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation
ClinicalTrials.gov study NCT04500717. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
ClinicalTrials.gov study NCT05957510. IPD Sharing: NO. Countries: 1. Publications: 1.
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
ClinicalTrials.gov study NCT01608841. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
ClinicalTrials.gov study NCT04184921. IPD Sharing: NO. Countries: 1. Publications: 5.
Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib
ClinicalTrials.gov study NCT00815971. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT01580735. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
ClinicalTrials.gov study NCT00372515. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.